Empowered!

EXPLORE

Society & Culture

Health & Fitness

© 2024 PodJoint

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/39/f9/5a/39f95ae1-328a-af10-df33-007a7b9c190b/mza_15494078631398775856.jpg/600x600bb.jpg

Empowered!

Patient Empowerment Network

61 episodes

1 month ago

This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...

Show more...

Health & Fitness

All content for Empowered! is the property of Patient Empowerment Network and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...

Show more...

Health & Fitness

Episodes (20/61)

Empowered!

Empowering Providers to Empower Patients in Bladder Cancer Care

This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...

1 month ago

21 minutes

Empowered!

Empowering Providers to Close Gaps in Prostate Cancer Care

This inaugural episode of the Empowering Providers to Empower Patients (EPEP) podcast features Dr. Andrew Laccetti, medical oncologist and Director of Quality for Hematology and Medical Oncology at NYU Langone’s Perlmutter Cancer Center. Dr. Laccetti explores the rapidly evolving landscape of prostate cancer care and shares strategies for overcoming practice inertia, addressing healthcare disparities, and personalizing treatment to meet each patient where they are. Learn actionable approaches...

1 month ago

24 minutes

Empowered!

How AI Is Shaping the Future of Personalized and Proactive Cancer Care

In this DECODE episode, host Lisa Hatfield speaks with Dr. Virginia Sun of Massachusetts General Hospital about how AI, particularly large language models like ChatGPT, is already changing cancer care. From identifying immune-related side effects to easing documentation burdens, they explore what’s hype, what’s real, and what patients should know as they navigate cancer in an increasingly tech-driven world.

2 months ago

33 minutes

Empowered!

Understanding Artificial Intelligence and Its Direct Impact on Cancer Care

In this DECODE podcast, Empowerment Lead Lisa Hatfield and Dr. Virginia Sun explore how artificial intelligence, especially large language models (LLMs), is transforming cancer care. From diagnosing adverse events to streamlining clinician workflows, they unpack what patients need to know, clarify common concerns, and discuss how AI can improve outcomes while preserving the irreplaceable human connection in medicine. Link to full transcript. See more from DECODE: powerfulpatients.org/decode

3 months ago

28 minutes

Empowered!

Myeloma Patient Expert Q&A: Dr. Ola Landgren

START HERE bridges the gap between expert and patient voices, empowering myeloma patients to feel comfortable asking precise questions of their healthcare team.In this webinar, Dr. Ola Landgren delves into the emerging and exciting therapies and clinical trials for myeloma, discusses the latest options for relapsed disease, and explores the current landscape of managing and monitoring multiple myeloma. Watch as Dr. Landgren answers patient-submitted questions and discusses another hot topic: ...

1 year ago

44 minutes

Empowered!

Evolving Myeloma Treatment Options: How You Can Access Cutting-Edge Care

With the quickly evolving landscape of myeloma treatment and care, it’s important to work with your healthcare team to determine a care plan. In this program, Dr. Omar Nadeem discusses the latest updates in research and clinical trials, the role of new and emerging therapies-- including bispecific antibodies and CAR T-cell therapy--and shares advice for accessing quality myeloma care.Dr. Omar Nadeem is the Clinical Director of the Myeloma Immune Effector Cell Therapy Program and Associate Dir...

1 year ago

30 minutes

Empowered!

Evolving Myelofibrosis Treatment Options: What You Should Know

Myelofibrosis treatment and care is evolving quickly so it’s essential to understand your options and work with your healthcare team when making treatment decisions. In this webinar, Dr. Gaby Hobbs will discusses the latest updates in research and clinical trials, the role of new and emerging myelofibrosis therapies, and shares advice for accessing quality care.Dr. Gabriela Hobbs is a hematology-oncology physician specializing in the care of patients with myeloproliferative neoplasms (MPN), c...

1 year ago

30 minutes

Empowered!

Kidney Cancer Patient Expert Q&A: Dr. Moshe Ornstein

START HERE bridges the expert and patient voice, enabling patients facing a kidney cancer diagnosis to feel comfortable asking precise questions of their healthcare team.In this program, Dr. Moshe Ornstein offers invaluable insights into renal cell carcinoma (RCC), equipping newly diagnosed patients with essential information on treatment priorities, as well as strategies for managing progression and recurrence.Download Resource Guide

1 year ago

30 minutes

Empowered!

Myeloma Patient Expert Q&A: Dr. Sikander Ailawadhi

In this START HERE myeloma program, Dr. Sikander Ailawadhi from Mayo Clinic spotlights priorities in the rapidly expanding myeloma treatment landscape. Watch as Dr. Ailawadhi addresses pressing questions submitted by patients and families, providing invaluable guidance and reassurance in navigating the complexities of myeloma care.Download Guide | Descargar GuíaSee More from START HERE Myeloma

1 year ago

39 minutes

Empowered!

Head & Neck Cancer: What Do You Need to Know About Evolving Treatment and Research?

Head and neck cancer research is evolving rapidly, leading to expanded treatment options for patients. Expert and researcher Dr. Ezra Cohen discusses key factors that impact head and neck cancer treatment decisions, reviews emerging research, and provides tips for collaborating with your healthcare team.Dr. Ezra Cohen is a medical oncologist, head and neck cancer researcher and Chief Medical Officer of Oncology at Tempus Labs.Download Resource Guide

1 year ago

37 minutes

Empowered!

Thrive | Considering CAR T-Cell Therapy for Myeloma? What You Should Know

Dr. Beth Faiman, a myeloma expert and researcher, discusses factors that should be considered when deciding to undergo CAR T-cell therapy, advice for preparing for and after the process, and why a good support team is essential. Dr. Faiman also shares research updates in CAR T-cell therapy, and alternatives options to this myeloma treatment.Dr. Beth Faiman is an Adult Nurse Practitioner in the department of Hematologic Oncology and Blood Disorders at the Cleveland Clinic. Learn more about Dr....

1 year ago

35 minutes

Empowered!

HCP Roundtable: Critical Clinical Trial Conversations in the Expanding Myeloma Landscape

Treatment options for multiple myeloma have increased substantially, mainly attributed to advancements in clinical trials. More than ever, HCPs having conversations about trials is critical. Given that underrepresented communities bear a disproportionate burden of multiple myeloma, it becomes imperative to shift this paradigm.What are the optimal approaches to initiate these conversations early in the patient journey? How should HCPs effectively communicate information about clinical trials t...

1 year ago

32 minutes

Empowered!

HCP Roundtable: Best Practices for Talking About Clinical Trials With Myeloma Patients

Clinical trials represent tomorrow’s medicine today, yet not every patient confronting a myeloma diagnosis is informed about all available care options. Surprisingly, some patients and their care partners are never introduced to the possibility of participating in clinical trials. How can we alter the course? What strategies can healthcare professionals (HCPs) employ to effectively communicate information about clinical trials and guide patients through next steps?Experts Dr. Beth Faiman and ...

1 year ago

28 minutes

Empowered!

Follicular Lymphoma Patient Expert Q&A: Dr. Kami Maddocks

Follicular lymphoma expert, Dr. Kami Maddocks discusses the latest in follicular lymphoma, meaningful highlights from the American Society of Hematology 2023 meeting and answers questions submitted by patients and care partners.Dr. Maddocks is a hematologist/oncologist specializing in treating lymphatic diseases from The Ohio State University. See More from START HERE Follicular LymphomaDownload Guide | Descargar Guía

1 year ago

35 minutes

Empowered!

Gastric Cancer: How to Access the Best Care and Treatment for YOU

Advances in gastric cancer research have led to more personalized therapy for patients. Dr. Yelena Janjigian discusses how biomarker testing can help guide a patient’s prognosis and treatment path, reviews currently available gastric cancer therapies, and shares tips for self-advocacy.Dr. Yelena Janjigian is Chief of Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center. See More From INSIST! Gastric CancerDownload Resource Guide

1 year ago

30 minutes

Empowered!

What Non-Small Cell Lung Cancer Treatment is Right for You?

What’s the best approach for YOUR lung cancer? Dr. Isabel Preeshagul discusses the importance of engaging in your lung cancer care decisions, shares advice for working with your team to determine a treatment approach, and reviews factors that affect therapy options. Dr. Preeshagul also provides an update on the latest research and clinical trials.Dr. Isabel Preeshagul is a thoracic medical oncologist at Memorial Sloan Kettering Cancer Center. Download Program Resource GuideSee More From ...

1 year ago

26 minutes

Empowered!

Thrive | Advice for Managing Potential CAR T-Cell Therapy Side Effects

Dr. Adriana Rossi, a myeloma expert and researcher, discusses how CAR T-cell therapy has revolutionized care, the process for undergoing this therapy, common side effects of this treatment, and advice for patients considering this option. Dr. Rossi also shares updates in CAR T-cell therapy research and explains what she’s excited about in myeloma care.Dr. Adriana Rossi is Co-director of the CAR T and stem cell transplant program at the Center for Excellence for Multiple Myeloma at Mount Sinai...

1 year ago

28 minutes

Empowered!

CLL Patient Expert Q&A: Dr. Danielle Brander

START HERE bridges the expert and patient voice, enabling chronic lymphocytic leukemia (CLL) patients to feel comfortable asking questions of their healthcare team with precision. In this program, CLL expert Dr. Danielle Brander speaks to managing CLL side effects, emerging novel CLL therapies and treatment options for CLL progression.Dr. Danielle Brander is an Assistant Professor in the Division of Hematologic Malignancies & Cellular Therapy at Duke University Medical Center. Learn more ...

2 years ago

35 minutes

Empowered!

CAR T-Cell Therapy Care Partners | Understanding Your Role in Patient Care and Recovery

Understanding CAR T-cell therapy and recovery is vital for care partners who are caring for a loved one undergoing this treatment approach. Dr. Shambavi Richard explains the CAR T-cell therapy process, potential complications, ongoing research in the field, and discusses how care partners can provide support at each stage of the process.Dr. Shambavi Richard is the Co-Lead Physician for the Multiple Myeloma CAR-T Program at Mount Sinai Tisch Cancer Center. Learn more about Dr. Shambavi Richard...

2 years ago

31 minutes

Empowered!

Follicular Lymphoma Patient Expert Q&A: Start Here

The START HERE program bridges lymphoma expert and patient voice, whether you are newly diagnosed, in active treatment or in watch and wait. In this webinar, Dr. Sameh Gaballa provides an overview of the latest in follicular lymphoma, emerging therapies, clinical trials and options for follicular lymphoma progression and recurrence.Dr. Sameh Gaballa is a hematologist/oncologist specializing in treating lymphoid malignancies from Moffitt Cancer Center. Learn more about Dr. Gaballa.See More fro...

2 years ago

31 minutes